MedPath

Comparison of body composition analysis by densitometry with methods of microcirculation analysis and inflammatory cytokines

Completed
Conditions
ObesityVisceral adiposityEndothelial dysfunctionLow grade inflammation
Body composition
DXA
Obesity
Visceral adiposity
Endothelial dysfunction
Low grade inflammation
Microcirculation
Registration Number
TCTR20221018004
Lead Sponsor
IVERSIDADE DO ESTADO DO RIO DE JANEIRO - UERJ
Brief Summary

Adiposity assessed by DXA, notably, visceral adiposity tissue and anthropometric measures of adiposity have been demonstrated inverse correlations with blood flow from the forearm during reactive hyperemia, indicating a decline in endothelial function with advancing from adiposity. There was no impairment of endothelium-independent vasodilation in the groups evaluated. A decline in endothelial function was identified in individuals with greater levels of hs CRP.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
101
Inclusion Criteria

Inclusion criteria were age range between 18 and 50 years old, apparently healthy, without evidence of inflammatory state, blood pressure levels < 180 x 110 mm Hg and hyperglycemia or glycated hemoglobin, not compatible with DM diagnosis

Exclusion Criteria

The main exclusion criteria were: diabetes mellitus; hypertension with blood pressure (BP) levels greater or equal 180x110 mm Hg; history of acute myocardial infarction; stroke; peripheral arterial obstructive disease or deep vein thrombosis. Individuals with previous history of bariatric surgery, smoking or currently using statins, phosphodiesterase 5 inhibitors and anti-inflammatory drugs were excluded

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visceral adiposity single assessment dual-energy X-ray absorptiometry
Secondary Outcome Measures
NameTimeMethod
endothelial function single assessment venous occlusion plethysmography
© Copyright 2025. All Rights Reserved by MedPath